Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases Journal Article


Authors: Klemm, M.; Cheng, C.; Cassell, G.; Shuman, S.; Segall, A. M.
Article Title: Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases
Abstract: The study of biochemical pathways requires the isolation and characterization of each and every intermediate in the pathway. For the site-specific recombination reactions catalyzed by the bacteriophage λ tyrosine recombinase integrase (Int), this has been difficult because of the high level of efficiency of the reaction, the highly reversible nature of certain reaction steps, and the lack of requirements for high-energy cofactors or metals. By screening synthetic peptide combinatorial libraries, we have identified two related hexapeptides, KWWCRW and KWWWRW, that block the strand-cleavage activity of Int but not the assembly of higher-order intermediates. Although the peptides bind DNA, their inhibitory activity appears to be more specifically targeted to the Int-substrate complex, insofar as inhibition is resistant to high levels of non-specific competitor DNA and the peptides have higher levels of affinity for the Int-DNA substrate complex than for DNA alone. The peptides inhibit the four pathways of Int-mediated recombination with different potencies, suggesting that the interactions of the Int enzyme with its DNA substrates differs among pathways. The KWWCRW and KWWWRW peptides also inhibit vaccinia virus topoisomerase, a type IB enzyme, which is mechanistically and structurally related to Int. The peptides differentially affect the forward and reverse DNA transesterification steps of the vaccinia topoisomerase. They block formation of the covalent vaccinia topoisomerase-DNA intermediate, but have no apparent effect on DNA religation by preformed covalent complexes. The peptides also inhibit Escherichia coli topoisomerase I, a type IA enzyme. Finally, the peptides inhibit the bacteriophage T4 type II topoisomerase and several restriction enzymes with 2000-fold lower potency than they inhibit integrase in the bent-L pathway. (C) 2000 Academic Press.
Keywords: dna-binding proteins; enzyme inhibition; protein binding; enzyme inhibitor; enzyme activity; bacterial proteins; dna; genetic recombination; amino acid sequence; kinetics; recombination, genetic; escherichia coli; substrate specificity; peptides; vaccinia virus; base sequence; binding site; catalysis; nucleic acid conformation; inhibitory concentration 50; enzyme substrate complex; dna cleavage; peptide library; dna topoisomerase; dna topoisomerases, type i; integrases; vaccinia; dna, superhelical; recombinase; tyrosine derivative; vaccinia topoisomerase; bacteriophage lambda; bacteriophage t4; osmolar concentration; integrase inhibitors; priority journal; article; integration host factors; dna restriction enzymes; bacteriophage λ integrase; e. coli topoisomerase i; inhibitory peptides; type ii topoisomerase; hexapeptide; attachment sites, microbiological
Journal Title: Journal of Molecular Biology
Volume: 299
Issue: 5
ISSN: 0022-2836
Publisher: Academic Press Inc., Elsevier Science  
Date Published: 2000-06-23
Start Page: 1203
End Page: 1216
Language: English
DOI: 10.1006/jmbi.2000.3829
PUBMED: 10873446
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 18 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stewart H Shuman
    546 Shuman